NDC 0065-4273

Pazeo

Olopatadine Hydrochloride

Pazeo is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Olopatadine Hydrochloride.

Product ID0065-4273_5af2437d-3ae1-4671-8455-feec4d2022cb
NDC0065-4273
Product TypeHuman Prescription Drug
Proprietary NamePazeo
Generic NameOlopatadine Hydrochloride
Dosage FormSolution
Route of AdministrationOPHTHALMIC
Marketing Start Date2015-01-29
Marketing End Date2022-06-30
Marketing CategoryNDA / NDA
Application NumberNDA206276
Labeler NameAlcon Laboratories, Inc.
Substance NameOLOPATADINE HYDROCHLORIDE
Active Ingredient Strength7 mg/mL
Pharm ClassesDecreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
NDC Exclude FlagN

Packaging

NDC 0065-4273-25

1 BOTTLE, DROPPER in 1 CARTON (0065-4273-25) > 2.5 mL in 1 BOTTLE, DROPPER
Marketing Start Date2015-01-29
Marketing End Date2022-06-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0065-4273-27 [00065427327]

Pazeo SOLUTION
Marketing CategoryNDA
Application NumberNDA206276
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-01-29

NDC 0065-4273-25 [00065427325]

Pazeo SOLUTION
Marketing CategoryNDA
Application NumberNDA206276
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-01-29

Drug Details

Active Ingredients

IngredientStrength
OLOPATADINE HYDROCHLORIDE7 mg/mL

OpenFDA Data

SPL SET ID:13c52523-32ad-b865-eeaa-56b301151779
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1601091
  • 1601086

    • Pharmacological Class

    • Decreased Histamine Release [PE]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Inhibitor [EPC]

    NDC Crossover Matching brand name "Pazeo" or generic name "Olopatadine Hydrochloride"

    NDCBrand NameGeneric Name
    0065-4273Pazeoolopatadine hydrochloride
    17478-105OlopatadineOlopatadine Hydrochloride
    17478-305OlopatadineOlopatadine Hydrochloride
    0093-7684Olopatadine HydrochlorideOlopatadine Hydrochloride
    0363-0200OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDE
    0363-8022OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDE
    0378-8023Olopatadine HydrochlorideOlopatadine Hydrochloride
    0065-0272PATADAYolopatadine hydrochloride
    0065-0816PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-8150PATADAY ONCE DAILY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-4274PATADAY TWICE A DAY RELIEFOLOPATADINE HYDROCHLORIDE
    0065-0332PATANASEolopatadine hydrochloride
    0078-0834PATANASEolopatadine hydrochloride
    0065-0271Patanololopatadine hydrochloride

    Trademark Results [Pazeo]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PAZEO
    PAZEO
    85766341 4748353 Live/Registered
    Novartis AG
    2012-10-29
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.